Dorsey & Whitney Trust CO LLC increased its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 5.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,327 shares of the financial services provider’s stock after buying an additional 237 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in CME Group were worth $851,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Norges Bank bought a new stake in CME Group in the fourth quarter valued at $959,260,000. Capital International Investors boosted its stake in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. PineStone Asset Management Inc. grew its position in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. Capital Wealth Planning LLC acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $253,563,000. Finally, Capital World Investors raised its holdings in shares of CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after buying an additional 1,172,575 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
CME Group Stock Down 0.0 %
CME stock opened at $218.48 on Wednesday. The firm has a market cap of $78.67 billion, a PE ratio of 24.86, a P/E/G ratio of 8.92 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a 50 day simple moving average of $204.40 and a 200 day simple moving average of $207.55.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.11%. CME Group’s dividend payout ratio is currently 52.33%.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Piper Sandler restated an “overweight” rating and set a $225.00 price objective on shares of CME Group in a research note on Tuesday, August 20th. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Barclays upped their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $209.73.
Read Our Latest Report on CME Group
Insiders Place Their Bets
In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Airline Stocks – Top Airline Stocks to Buy Now
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- Want to Profit on the Downtrend? Downtrends, Explained.
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.